FindDrugs.org

Gala Health Review

Brand-level review · Last reviewed Sep 23, 2026

5.67/10

Operator-trust score

The brand-level factors every category shares — legitimacy, transparency, sentiment, privacy, support — not price or per-treatment value.

Cash-pay

Our verdict

Gala is a three-line telehealth brand aimed at women in midlife, and it splits cleanly on disclosure. It publishes what most of this category hides — a headline price before signup on every line, the FDA-labelled BMI thresholds and the labelled contraindications on its GLP-1 drug pages, a full administration protocol for sermorelin, and, on the longevity pages, an unusual admission in its own words that there is no clinical trial for the compound bundle to cite. It hides what much of the category now publishes: no compounding pharmacy is named on any line, no individual clinician is named anywhere, and the menopause pages carry four outcome percentages with no source and never state which regulatory category the hormones fall into — an approved product, or a compounded preparation.

Gala Health plans & reviews by category

Each category is scored separately. Read the full review where one exists — or check current pricing directly.

  • Compounded GLP-1/GIP (incl. tirzepatide) · injection$179/mo
  • Ozempic® (branded semaglutide) · injection$1299/mo
  • Wegovy® pill (oral semaglutide) · oralnot published — listed as “Coming soon”
  • Estradiol (pill or patch) · oral$69/mo
  • Progesterone · oralincluded in the from-$69/month HRT pricing; no separate figure published
  • Vaginal estradiol · topicalno separate figure published
  • Non-hormonal options · oralno separate figure published
  • NAD+ (nicotinamide adenine dinucleotide) · injection$199/mo
  • Sermorelin · injection$199/mo

Prices as of Sep 23, 2026 — verify current on the brand's site.

Key takeaways

  • Three lines: GLP-1 weight loss, menopause hormone therapy, and two longevity peptides (NAD+ and sermorelin)
  • A headline price is published before signup on every line — $179/month compounded GLP-1, $69/month HRT, $199/month per longevity compound
  • GLP-1 pages publish the FDA-labelled BMI thresholds and the labelled contraindications; the HRT pages publish neither
  • Compounded GLP-1 is labelled not FDA-approved repeatedly; the HRT and longevity lines carry no equivalent labelling
  • No compounding pharmacy is named on any line, and no 503A/503B classification is published
  • No individual clinician is named; the homepage shows Harvard, Columbia and Mount Sinai logos under a line claiming where its doctors trained and practised
  • Billing starts at intake; cancellation needs 72 hours' notice and, outside medical disqualification, no refund is issued on cancellation

What is Gala Health?

Gala GLP-1 is the consumer brand of AI Coaching Inc., a Delaware-registered company selling cash-pay telehealth to women in midlife across three lines: compounded and branded GLP-1 weight-loss medication, menopause hormone therapy, and two longevity peptides. Gala says it provides administrative, technology and management services and does not itself provide medical care — prescribing is done by clinicians affiliated with independently owned practices, including OpenLoop-affiliated medical groups. It says it operates in all 50 states, takes no insurance, and accepts FSA and HSA.

Is Gala Health legit?

Nothing adverse sits on any public record we could reach, and nothing affirmative is claimed either. The FDA enforcement register returns no entry for Gala or AI Coaching, and the BBB holds no business profile under any spelling we tried — both measured on 22 September 2026 with a control query that returns entries for other brands in this corpus, so those are measurements rather than failed searches. Against that, Gala claims no third-party accreditation, names no compounding pharmacy and names no individual clinician, and its homepage shows three medical-school logos under a line about where its doctors trained, with nothing published to check that against.

  • Corporate identity: AI Coaching Inc., d/b/a Gala GLP-1, is named in the terms of service and the site footer, with a Wilmington, Delaware address and a support email — Gala (galaglp1.com), Sep 2026.
  • Regulatory record: The FDA enforcement register returns no entry for Gala or AI Coaching, and the BBB holds no business profile, measured 22 September 2026 with a control that returns entries for other brands — FDA enforcement register, Sep 2026.
  • Accreditation: None is claimed anywhere on the site and none was verified. There is no LegitScript, NABP or pharmacy-accreditation badge on any page — Gala (galaglp1.com), Sep 2026.
  • Clinician model: Gala says medical services come from clinicians affiliated with independently owned practices including OpenLoop-affiliated groups, and that Gala does not provide medical care. No individual clinician is named — Gala (galaglp1.com), Sep 2026.
  • Medication & pharmacy: Gala says it works with a wide network of pharmacies across all 50 states and sources ingredients from FDA-regulated suppliers. It names no pharmacy and publishes no 503A/503B classification — Gala (galaglp1.com), Sep 2026.

Treatment options

What Gala Health actually treats. Pricing lives in the plans table above and in each category review.

  • Compounded GLP-1/GIP including tirzepatide

    from $179/month on a yearly plan

  • Branded Ozempic®

    $1,299/month

  • Wegovy® pill

    listed as coming soon, not purchasable at review

  • Estradiol pill or patch, progesterone, vaginal estradiol and non-hormonal options

    HRT from $69/month

  • NAD+

    $199/month for a 28-day supply, or $118/month on a 12-month plan

  • Sermorelin

    $199/month for a 28-day supply, or $118/month on a 12-month plan

Pros & cons

Pros

  • A headline price is published before signup on all three lines, which most of this category does not do
  • GLP-1 eligibility is published before signup at the FDA-labelled thresholds — BMI ≥ 27 with a weight-related condition, or ≥ 30 without
  • Labelled contraindications are published on both GLP-1 drug pages
  • Compounded GLP-1 is labelled not FDA-approved in Gala's own pricing footnote and throughout its FAQ
  • The longevity pages state in Gala's own words that there is no clinical trial for the compound bundle to cite
  • Four HRT routes are offered, including a published non-hormonal path
  • Gala says dose changes, kit switches and provider messaging carry no extra charge

Cons

  • No compounding pharmacy is named on any line, and no 503A or 503B classification is published
  • No individual clinician is named anywhere on the site
  • The homepage displays Harvard, Columbia and Mount Sinai logos under a claim about where its doctors trained, with nothing published to check it against
  • The HRT pages publish four outcome percentages with no source attached
  • The HRT pages never state which regulatory category the hormones fall into — an approved product, or a compounded preparation, though the GLP-1 line is labelled
  • Sermorelin lists elevated IGF-1 as an exclusion but describes no bloodwork that would detect it
  • Billing starts at intake, cancellation requires 72 hours' notice, and outside medical disqualification the published policy is that no refund is issued
  • Two different entry prices are advertised for GLP-1 — $179/month on the homepage and $199/month in the FAQ — on different commitments

The bottom line

Gala is a reasonable choice if a published price and published screening criteria matter more to you than knowing who compounds your medication, and its longevity pages are more honest about evidence than this category's norm. Before starting on any line, ask which specific product you are being prescribed, whether it is FDA-approved or compounded, and which pharmacy fills it — Gala's own pages answer the first question only on the GLP-1 side and never answer the third.

Review score changes

The timeline above is this brand's Operator Trust Score. Each review below is scored separately, and keeps its own history.

  • Anti-Aging / NAD+ review— no recorded score change yet
  • Anti-Aging / Sermorelin review— no recorded score change yet
  • Hormone Therapy / HRT (menopause) review— no recorded score change yet
  • Weight Management / GLP-1 review— no recorded score change yet

Work at Gala Health?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Completeness was not recorded for this score · 11 sources cited

Regulatory

Other

What we couldn't verify

  • Gala names no pharmacy on any of its three lines, saying only that it works with “a wide network of pharmacies across all 50 states” and that ingredients come from FDA-regulated suppliers. No licence number and no 503A or 503B classification appears anywhere on the site. This is an absence on Gala's own pages, confirmed across the homepage, the About FAQ and every product page, not a retrieval failure.
  • Gala says it has more than 50,000 patients and its pages carry a Trustpilot mark. trustpilot.com returned HTTP 403 to automated retrieval on 2026-09-22, and trustpilot.com is recorded `refused` on terms, so no rendered fetch is available either; solving or routing around the block is not a retrieval method this project uses. The counters on Gala's own pages render as zero without client-side scripting, so no rating or volume was readable there. FindDrugs therefore holds no sentiment figure it retrieved itself and publishes none. THIS IS NOT A FINDING THAT THE CLAIM IS FALSE.
  • The federal-docket check ran on 2026-09-21 against the CourtListener REST API v4 (the only sanctioned route — courtlistener.com is refused on terms), with the positive control “Mochi Health” returning 15 records, so the search works. All three queries — “AI Coaching Inc”, “Gala GLP-1” and “Gala Health” — returned records whose case captions contain none of those strings: the matches are case body text about unrelated matters, because the names match ordinary English words. That is TOO GENERIC TO BE EVIDENCE and supports no claim in either direction. There is no measured absence here, and nothing on any Gala page says there is.
  • Gala's homepage displays the three institutions' logos under a line claiming where its doctors trained and practised. No clinician is named anywhere on the site, and nothing is published that would let the affiliation be checked — no name, no credential, no institution-side listing. The claim is recorded as one Gala makes and is not repeated as established anywhere in this review.
  • The page publishes hot flashes resolved at eight weeks, sleep improvement, mood and anxiety relief and bone-loss reduction as percentages, with no source attached to any of them. FindDrugs holds no record for these figures and does not repeat them as findings; they are reported as claims Gala makes.
  • Gala labels its GLP-1 line as not FDA-approved repeatedly and prominently, but the hormone pages carry no equivalent statement. They describe the products as “bioidentical”, which is a marketing term covering both FDA-approved products and compounded preparations, so the question is unresolved on Gala's own pages.
  • Gala's sermorelin page lists elevated prolactin or IGF-1 among the conditions that make the peptide inappropriate, but nothing on the page describes a baseline IGF-1 draw or any bloodwork, and the stated follow-up is a quarterly asynchronous questionnaire. Whether a test happens inside the intake is not published.
  • Gala says licensed providers in all 50 states across each of its three lines. That statement was not verified against state licence records; no such record was retrieved for this review.
Last reviewed Sep 23, 2026View the ledger